Biomarker Tests Market Proceeds To Witness Huge Upswing Over Assessment Period by 2027
Research Reports
Jan 27, 2021
Growing patient engagement in personal healthcare, increasing demand for biomarkers in other technologies such as next-generation sequencing technology, ultra-high – performance sequencing, the prevalence of genetic diseases, and the prospects for biomarkers in selective therapies are some of the factors driving market development. As well as advancements in nutrition, people are becoming more mindful of health and well-being. Improving the propensity of people for customized health care is driving the growth of the sector.
The biomarker test market is growing mainly due to the rising prevalence of genetic disorders. According to a recent study report published by the Market Research Future, Global Biomarker Tests Market accounted for USD 9,375 million in 2019 and is projected to reach USD 31859.73 Million by 2027 and register 14.60% CAGR during the forecast period.
Regional Overview
Europe, Asia-Pacific, North America, and the Middle East & Africa are the focus of the global demand for biomarker research.
In 2018, due to high disease risk, the presence of major industry players, favourable policy and regulatory policies, and the growing adoption of biomarker testing in the United States and Canada, North America led the market. The presence of business giants such as Pfizer Inc., Quest Diagnostics, Abbott, Thermo Fisher Science, Inc., and Bio-Rad Laboratories, Inc. makes it possible for the medication to be shipped promptly to the consumer, thereby leading to national business development.
Request Free Sample Copy of Report with Detailed Impact Analysis of Covid-19:https://www.marketresearchfuture.com/sample_request/3570
Thanks to rising cases of cardiovascular disease, booming healthcare industries and rising pharmaceutical technology advances, Europe is expected to be the second largest region on the market. According to figures published by the European Heart Network , for example, coronary artery disease causes 3.9 million deaths annually in Europe and more than 1.8 million deaths in the European Union ( EU).
Competitive Dynamics
The eminent players in the global biomarker tests market are Pfizer Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline plc, GE Healthcare, Medtronics plc, Novartis AG, and Quest Diagnostics.
Segmental Analysis
The global market for biomarker tests has been split into the application and end-user groups.
The global market has been broken into aids, lung illnesses, infectious conditions, the central nervous system, and others, based on the application. The global market is categorized into pharmaceutical & medical firms, research instrument firms, healthcare IT / big data companies, and clinical laboratories on an end-user basis.
Have Any Query? Connect with Our Research Expert 24*7:https://www.marketresearchfuture.com/enquiry/3570
In 2018, due to the cancer cases and growing demand for fast and accurate testing tools and personalized drugs, the cancer segment dominated the market by application. In 2018, cancer was the world’s second leading cause of death and accounted for almost 9.6 million deaths, according to the World Health Organisation (WHO), for instance. Around one in six deaths were caused by cancer globally in 2018.
About Market Research Future:
Market Research Future (MRFR) is a world-renowned market research company that offers a wide range of services, complete with accurate and precise analysis about diverse markets, sub-markets and target consumers. Our approach is a combination of extensive information and multiple data sources that help provide an exhaustive comprehension about the latest major developments to the client, in addition to future events and what measures and decisions to take on the basis of the same.
Our fast emerging market research firm is armed with an adept research analysts’ team that focuses on gathering useful data and analytics in terms of economic and technological advances. Our proficient analysts conduct industrial visits in a bid to achieve reliable and accurate information from established market participants. One of our foremost objectives is to keep the client well-versed with all the lucrative opportunities as well as challenges surrounding various global markets. We offer step-by-step guidance to our clients, through consulting and strategic services, enabling them to arrive at a practical and effective decision.
Tags:
, Reportedtimes, Research Newswire, English




